EcoDrugPlus

Ensembl ID : ENSBGRG00000014323
Gene Symbol: -
Cross references: -
91 Possible Orthologues:

Ensembl ID : ENSBGRG00000026166
Gene Symbol: -
Cross references: -
124 Possible Orthologues:

Ensembl ID : ENSBGRG00000005029
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSBGRG00000016466
Gene Symbol: -
Cross references: -
79 Possible Orthologues:

Ensembl ID : ENSBGRG00000005012
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSBGRG00000012031
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSBGRG00000002876
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Ensembl ID : ENSBGRG00000002714
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSBGRG00000004961
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSBGRG00000004908
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSBGRG00000004261
Gene Symbol: -
Cross references: -
401 Possible Orthologues:

Ensembl ID : ENSBGRG00000025116
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).